Kyna Pharmaceuticals

What Kyna Pharmaceuticals does

Kyna Pharmaceuticals is an India-based PCD (Propaganda Cum Distribution) Pharma Franchise company operating as a division of Albia Biocare, headquartered in Panchkula, Haryana. Founded in 2016 by industry professionals with 20+ years of pharmaceutical experience, the company recruits individual franchise partners and small distributors across India, granting them monopoly rights for specific territories and supplying them with a broad portfolio of DCGI-approved pharmaceutical formulations. The product catalogue spans 16+ therapeutic categories—including analgesics, antibiotics, gynecology, dermatology, pediatrics, neurology, orthopedics, hepatology, dental, and nutraceuticals—delivered in multiple dosage forms (tablets, capsules, softgels, syrups, drops, injectables, ointments, granules, oils, powders, sachets). Products are manufactured through GMP-certified and WHO-compliant third-party manufacturing units, with Kyna providing promotional materials, visual aids, technical literature, and same-day dispatch support to its franchise network.

The business operates two revenue streams: (1) PCD pharma franchise sales to territory-based distributors, priced via quote-based multi-year contracts, and (2) third-party/contract manufacturing services for other pharmaceutical companies seeking outsourced production. Customer acquisition runs through a digital-and-direct GTM motion—website inquiry forms, WhatsApp contact (+91-9988 289 049), email ([email protected]), and organic social presence on Facebook, LinkedIn, and Twitter—targeting qualified individuals and corporates seeking pharmaceutical distribution businesses. The company holds ISO 9001:2008 certification and claims GMP/WHO-compliant operations, with 5/5 customer ratings across 131 reviews serving as its primary reputational signal.

Kyna is a micro-enterprise with 1-10 employees, no disclosed funding, no institutional investors, and no disclosed revenue. The named director is Pankaj Goyal (B.E. Hons., MBA). The company claims operational reach into South Asia and Africa alongside its India base, though testimonial evidence is concentrated in Indian states (UP, Madhya Pradesh, Bihar, Manipur). It operates within a highly fragmented Indian PCD pharma franchise market where competitive differentiation relies on regulatory compliance, franchise support quality, and breadth of therapeutic coverage rather than technology or scale advantages.

Name

Kyna Pharmaceuticals

Legal name

Kyna Pharmaceuticals

Website

https://kyna.in

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Kyna Pharmaceuticals is an India-based PCD pharma franchise company (division of Albia Biocare) that supplies DCGI-approved formulations across 16+ therapeutic categories to territory-based distributor partners, also offering third-party manufacturing services to other pharma companies.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Pharmaceutical formulations
• PCD pharma franchise
• Third party manufacturing
• Generic medicines
• Pharma distribution

Headquarters

HQ city

Chandigarh

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D

Revenue model

1. PCD Pharma Franchise: Revenue generated through selling pharmaceutical products to franchise partners/distributors across India. Partners receive marketing and distribution rights for assigned territories along with promotional support and technical literature.
2. Third Party/Contract Manufacturing: Manufacturing services for other pharmaceutical companies who want to outsource production, allowing focus on core competencies like marketing and distribution.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Kyna Pharmaceuticals is a PCD (Propaganda Cum Distribution) Pharma Franchise company that distributes a wide range of DCGI-approved pharmaceutical formulations — tablets, capsules, softgels, syrups, drops, ointments, granules, oils, powders, and injectables — to franchise partners across India. Products are sourced from GMP Certified/WHO compliant manufacturing units and span 16+ therapeutic categories including antibiotics, analgesics, gynecology, pediatrics, dermatology, neurology, and nutraceuticals. The company also offers third-party/contract manufacturing services for other pharmaceutical businesses.

Product overview

Kyna Pharmaceuticals (a division of Albia Biocare) is a PCD Pharma franchise company offering a comprehensive portfolio of pharmaceutical products across multiple therapeutic categories. The company provides DCGI-approved formulations including Tablets, Capsules, Softgels, Syrups, Suspensions, Drops, Ointments, Injectables, Granules, Oils, Powders, and Sachets. Product ranges span Analgesics and NSAIDs, Anti-acids and Gastroenterology, Antibiotics, Anti-cough/cold/Allergic, Anti-malarial/Anti-Infectives, Anti-Ulcerative, Dental, Dermatology, Gynecology, Genito-Urinary, Hepatology, Multivitamins/Antioxidants, Neurology/Psychiatry, Orthopedics, Pediatrics, and Nutraceuticals. The company operates GMP Certified/WHO compliant manufacturing units and offers products through PCD franchise, pharma franchise on monopoly basis, and third-party manufacturing services.

Differentiator

Problem solved

Functional benefit

Products and services

• PCD Pharma Franchise A franchise-based distribution program that recruits qualified individuals and corporates across India as business associates. Partners receive monopoly rights for designated territories along with complete ecosystem support including technical literature, promotional materials (Visual Aids, Product Glossary, LBLs, Sample Catch covers), and a full portfolio of DCGI-approved pharmaceutical formulations at competitive rates. Designed for entrepreneurs looking to start or expand a pharmaceutical distribution business in India.
• Third Party / Contract Manufacturing Contract manufacturing services for pharmaceutical companies that want to outsource production while focusing on their core competencies such as marketing and distribution. Production leverages GMP Certified/WHO compliant manufacturing units capable of producing tablets, capsules, softgels, syrups, drops, ointments, injectables, granules, oils, powders, and sachets across multiple therapeutic categories.
• Pharmaceutical Product Portfolio A broad portfolio of DCGI-approved pharmaceutical formulations spanning therapeutic categories including Analgesics and NSAIDs, Anti-acids and Gastroenterology, Antibiotics, Anti-cough/Cold/Allergic, Anti-malarial/Anti-Infectives, Anti-Ulcerative, Dental, Dermatology, Gynecology, Genito-Urinary, Hepatology, Multivitamins/Antioxidants, Neurology/Psychiatry, Orthopedics, Pediatrics, and Nutraceuticals. Available dosage forms include tablets, capsules, softgels, syrups, suspensions, drops, ointments, injectables, granules, oils, powders, and sachets.

Quantifiable outcome

• Order execution within 24 hours
• +1 more outcomes

Named customers7 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Albia BiocarecoreOthersKyna Pharmaceuticals is a division of Albia Biocare, a PCD Pharma company in India. The parent company provides strategic direction and shared resources across multiple pharmaceutical divisions including Kyna, Albia, and Burdock Labs.

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Albia Biocare: Parent organization of Kyna Pharmaceuticals and itself a PCD pharma franchise company in India, offering generic formulations through franchise partners with comparable territory-monopoly and promotional-support models.
• Burdock Labs: Sister division under the Albia Biocare umbrella, also focused on pharma franchise distribution in India; comparable therapeutic breadth and franchise-led GTM.
• Monark Biocare: Indian PCD pharma franchise company offering generic formulations (tablets, capsules, syrups, injectables) to franchise partners across India, directly comparable in business model and product breadth.

Broad incumbents

• Lupin: Major Indian pharmaceutical company with a wide formulation portfolio spanning multiple therapy areas; comparable product range and India-centric generic pharma focus.
• Sun Pharmaceutical Industries: Largest pharmaceutical company in India with a broad generics and specialty formulation portfolio; comparable therapeutic categories and India/global distribution model, though orders of magnitude larger.
• Mankind Pharma: Leading Indian pharma company with strong formulation franchise and distribution across India; comparable breadth across therapeutic categories and India-centric GTM.
• Cipla: Major Indian generic pharmaceutical manufacturer with a wide formulation portfolio across multiple therapeutic categories; comparable product range and therapy-area overlap, though operates at vastly larger scale with global footprint.
• Akums Drugs & Pharmaceuticals: One of India's largest contract pharma manufacturers producing oral solids, liquids and injectables; comparable in third-party manufacturing services and dosage-form capability, though significantly larger.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/mamtgoya
• Facebookfacebook.com/kyna.in
• LinkedInlinkedin.com/company/kynapharmaceuticals

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kyna Pharmaceuticals